期刊文献+

不同免疫球蛋白启动子控制的白喉毒素A链基因对淋巴瘤细胞的抑制作用

Selective effectiveness of the diphtheria toxin A chain coding sequence linked to different murine immunoglobulin promoter and enhancer on lymphoma cells
暂未订购
导出
摘要 目的比较免疫球蛋白κ轻链启动子/增强子和免疫球蛋白重链启动子/增强子控制的白喉毒素A链基因对淋巴瘤细胞生长抑制。方法将白喉毒素A链基因或细菌β半乳糖苷酶基因与免疫球蛋白启动子/增强子相连构建成白喉毒素A链真核表达载体pcDNA3IgκDTA、pcDNA3IgHDTA或细菌β半乳糖苷酶真核表达载体pcDNA3IgκLacZ、pcDNA3IgHLacZ。由脂质体介导将质粒转染至产或不产免疫球蛋白的真核细胞中,检测β半乳糖苷酶基因在不同细胞中的表达水平,并进一步检测白喉毒素A链基因的表达对转染细胞的生长抑制作用。结果由免疫球蛋白κ轻链启动子/增强子或免疫球蛋白重链启动子/增强子控制的β半乳糖苷酶基因只能在产免疫球蛋白(κ轻链型)细胞株CA46中表达。当β半乳糖苷酶基因与质粒pcDNA3IgκDTA或pcDNA3IgHDTA共转染时,β半乳糖苷酶基因的表达只在CA46细胞中被抑制。质粒pcDNA3IgκDTA、pcDNA3IgHDTA的表达均能明显抑制CA46细胞的生长,而对照质粒pcDNA3IgκLacZ或pcDNA3IgHLacZ对CA46细胞则无明显作用,并且pcDNA3IgκDTA的抑制作用较pcDNA3IgHDTA更强。结论由免疫球蛋白κ轻链启动子/增强子或免疫球蛋白重链启动子/增强子控制的白喉毒素A链基因的表达能特异性地杀伤产免疫球蛋白(κ轻链)的肿瘤细胞。并且免疫球蛋白κ轻链启动子/增强子较免疫球蛋白重链启动子/增强子有更强的启动转录活性。 Objective To test whether the diphtheria toxin A chain coding sequence linked to murine immunoglobulin K-light chain (IgK) or heavy chain(IgH) promoter and enhancer exert cytocidal effect selec- tively on IgKor IgH producing cells. Methods The mammalian expression vectors containing the diphtheria toxin A chain coding sequence, controlled by murine immunoglobulin K-light chain(IgK) or heavy chain(IgH) promoter and enhancer, were transfected into the lymphoma cell line CA46 by the liposome-coated DNA meth- od. Expression of β-galactosidase(β-gal) activity and effects on cell growth of transfected cells were assessed. Results Expression of [3-gal under the control of IgKor IgH promoter was detected only in immunoglobulin pro- ducing cell line CA46. Expression of β-gal was greatly suppressed when co transfected with pcDNA3IgKDTA or pcDNA3IgHDTA in CA46 cells. Cell growth of CA46 cells transfected with pcDNA3IgKDTA plasmid was signif- icantly inhibited compared with CA46 cells transfected with pcDNA3IgHDTA. Conclusion Selective killing of inununoglobulin producing cells can be attained by introducing the diphtheria toxin A gene under the control of of IKor IgH oromoter and enhancer, esoecially under the control of IgKor IgH promoter and enhancer.
作者 姚娜 芮红兵
出处 《中国实用医药》 2012年第16期1-4,共4页 China Practical Medicine
关键词 基因治疗 白喉毒素 免疫球蛋白 Gene therapy Diphtheria toxin Immunoglobulin
  • 相关文献

参考文献13

  • 1Maxwell IH,Maxwell F,Glode LM. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells:possible strategy for inducing cancer cell suicide[J].Cancer Research,1986,(09):4660-4664.
  • 2Yoshihiko Murayama,Takushi Tadakuma,Michito Kumitomi. Cell-specific expression of the diphtheria toxin A-chain coding sequence under the control of the upstream region of the human alpha-fetoptrotein gene[J].Journal of Surgical Oncology,1999,(03):145-149.
  • 3Palmiter RD,Behringer RR,Quaife CJ. Cell lineage ablation in transgeinc mice by cell-specific expression of a toxin gene[J].Cell,1987,(03):435-443.
  • 4Breitman ML,Clapoff S,Rossant J. Genetic ablation:programmed lineage suicide by tissue-specific expression of the diphtheria toxin A gene in transgenic mice[J].Science,1987,(4833):1563-1565.
  • 5Maxwell IH,Glode M,Maxwell F. Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells[J].Cancer Research,1991,(16):4299-4304.
  • 6Sambrook J,Fritsch E F,Maniatis T. Molecular Cloning:A Laboratory Manual[M].New York:cold Spring Harbor Laboratory Press,1989.804-809.
  • 7Shen Pang. Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene[J].Cancer Gene Therapy,2000,(07):991-996.
  • 8Mizrahi A,Czerniak A,Levy T. Development of targetedtherapyfor ovarian cancer mediated by a plasmid expressingdiphtheria toxinunder the control of H19 regulatory sequences[J].Journal of Traditional Medicines,2009,(06):69.
  • 9Smaldone MC,Davies BJ. BC-819,a plasmid comprising the H19 generegulatory sequences anddiphtheria toxinA,for the potential targetedtherapyof cancers[J].Current Opinion in Molecular Therapeutics,2010,(05):607-616.
  • 10Amit D,Tamir S,Birman T. Development of targetedtherapyfor bladder cancer mediated by a double promoter plasmid expressingdiphtheria toxinunder the control of IGF2-P3 and IGF2-P4 regulatory sequences[J].Int J Clin Exp Med,2011,(02):91-102.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部